SCHEMBL27199799

SCHEMBL27199799

c1cc2[nH]c3c4cnccc4ncc3c2cn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 4/20 0.50
PARP1 P09874 1/20 0.45
MAPT P10636 9/20 0.42
KIF11 P52732 1/20 0.41
CHEK1 O14757 1/20 0.40
FEN1 P39748 1/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
GMNN O75496 1/20 0.39
LMNA P02545 1/20 0.39
NR3C1 P04150 1/20 0.39
TP53 P04637 1/20 0.39
CYP1A1 P04798 1/20 0.39
CYP1A2 P05177 1/20 0.39
LCK P06239 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9316093 0.88 ACHE (0.59) ACHEPARP1MAPTCHEK1KDM4E
SCHEMBL27092615 0.79 ACHE (0.47) ACHEPARP1MAPTCHEK1KDM4E
SCHEMBL27136670 0.77 ACHE (0.53) ACHEPARP1MAPTCHEK1KDM4E
SCHEMBL972999 0.76 ACHE (0.78) ACHEPARP1MAPTKIF11FEN1
SCHEMBL29642993 0.76 ACHE (0.78) ACHEPARP1MAPTKIF11FEN1
SCHEMBL30877776 0.71 ACHE (0.50) ACHEPARP1MAPTKIF11KDM4E
SCHEMBL9315013 0.71 GABRA1 (0.43) ACHEPARP1MAPTKIF11CHEK1
SCHEMBL29351047 0.70 TOP2A (0.54) ACHEMAPTKIF11KDM4EALDH1A1
SCHEMBL2956894 0.70 TOP2A (0.54) ACHEMAPTKIF11KDM4EALDH1A1
SCHEMBL30866442 0.70 CHEK1 (0.43) ACHEPARP1MAPTCHEK1FEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11964976-B1 Substituted pyrido[3′,4′:4,5]pyrrolo[3,2-c][1,6]naphthyridines as CK2 inhibitors King Faisal University (SA) 2024-04-23 US disclosed
US-11964976-B1 Substituted pyrido[3′,4′:4,5]pyrrolo[3,2-c][1,6]naphthyridines as CK2 inhibitors King Faisal University (SA) 2024-04-23 US disclosed
US-11964976-B1 Substituted pyrido[3′,4′:4,5]pyrrolo[3,2-c][1,6]naphthyridines as CK2 inhibitors King Faisal University (SA) 2024-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11964976-B1 Substituted pyrido[3′,4′:4,5]pyrrolo[3,2-c][1,6]naphthyridines as CK2 inhibitors CKS2, CDK2, CDK1 ACHE 606/4885PARP1 927/4885MAPT 1111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.